SCHEMBL9364334

SCHEMBL9364334

COC(=O)/C=C(\C)NC(C(=O)O)c1ccc2nc(N)sc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
SCN4A P35499 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP3A4 P08684 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 1/20 0.41
CYP2C9 P11712 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KCNH2 Q12809 1/20 0.40
LMNA P02545 1/20 0.40
PIK3CA P42336 4/20 0.40
PI4KA P42356 4/20 0.40
PI4KB Q9UBF8 4/20 0.40
PIP5K1C O60331 2/20 0.40
ALKBH5 Q6P6C2 1/20 0.39
FTO Q9C0B1 1/20 0.39
CYP2D6 P10635 2/20 0.39
MAPT P10636 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9648060 1.00 RAB9A (0.47) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL9650878 0.91 RAB9A (0.46) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL27692947 0.91 RAB9A (0.46) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL9364323 0.91 RAB9A (0.46) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL8977487 0.78 RAB9A (0.49) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL9620028 0.78 RAB9A (0.53) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL9844859 0.76 NPC1 (0.43) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL9620030 0.74 CYP3A4 (0.51) RAB9ANPC1SCN4ASMN1; SMN2CYP3A4
SCHEMBL5995942 0.72 FOLH1 (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL2896479 0.72 FOLH1 (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0292806-B1 Substituted vinyl cephalosporins, process for their preparation and their use as medicines BAYER AG (DE) 1994-11-02 EP disclosed
US-5171854-A Antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1992-12-15 US disclosed
EP-0292806-A2 Substituted vinyl cephalosporins, process for their preparation and their use as medicines BAYER AG (DE) 1988-11-30 EP disclosed